rosuvastatin + olmesartan

Rosuvastatin + olmesartan is a fixed-dose combination drug consisting of two active pharmaceutical ingredients: rosuvastatin, an HMG-CoA reductase inhibitor (statin), and olmesartan medoxomil, an angiotensin II receptor blocker (ARB). This combination is used for the co-management of dyslipidemia (high cholesterol) and hypertension (high blood pressure), conditions that frequently coexist in patients at risk for cardiovascular disease. Rosuvastatin lowers LDL cholesterol by inhibiting HMG-CoA reductase in the liver, thereby reducing cholesterol synthesis. Olmesartan blocks the angiotensin II type 1 receptor on vascular smooth muscle, leading to vasodilation and reduced blood pressure. The fixed-dose combination aims to improve medication adherence by reducing pill burden while providing effective control of both lipid levels and blood pressure[1][2]. Clinical studies have shown that this combination is effective and safe for patients with mild to moderate hypertension accompanied by dyslipidemia[2].

Brand names

OlostarStocosil

Other names

rosuvastatin and olmesartanolmesartan medoxomil and rosuvastatin